News

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
Former Surgeon General Jerome Adams, who served under Trump’s first administration, criticized Kennedy’s move to cancel $500 million for mRNA projects. Adams said in a post on social media platform X ...
Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...
The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under ...